AVT-02 (adalimumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVT-02 (adalimumab), covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.